Avantor FY2026 EPS Estimate Boosted by Zacks Research

Avantor, Inc. (NYSE:AVTR) – Stock analysts at Zacks Research lifted their FY2026 EPS estimates for Avantor in a report released on Wednesday, August 19th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $0.80 for the year, up from their previous estimate of $0.78. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Avantor’s current full-year earnings is $0.81 per share. Zacks Research also issued estimates for Avantor’s Q4 2026 earnings at $0.22 EPS, Q1 2027 earnings at $0.18 EPS, Q2 2027 earnings at $0.22 EPS, Q3 2027 earnings at $0.22 EPS, FY2027 earnings at $0.85 EPS, Q2 2028 earnings at $0.23 EPS and FY2028 earnings at $0.92 EPS.

Several other analysts have also issued reports on the company. Royal Bank Of Canada boosted their price target on Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Morgan Stanley raised their price objective on Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $13.00 price objective on shares of Avantor in a research note on Thursday, July 30th. Finally, Stifel Nicolaus increased their target price on shares of Avantor from $8.00 to $15.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $12.00.

Avantor Trading Up 4.8%

NYSE:AVTR opened at $13.97 on Thursday. Avantor has a one year low of $7.26 and a one year high of $15.93. The business has a fifty day moving average price of $11.44 and a 200-day moving average price of $9.59. The firm has a market capitalization of $9.45 billion, a price-to-earnings ratio of -16.63, a price-to-earnings-growth ratio of 10.04 and a beta of 0.89. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. During the same quarter last year, the company posted $0.24 EPS. The company’s revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its stake in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after buying an additional 1,189 shares in the last quarter. Private Trust Co. NA lifted its position in shares of Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor in the second quarter valued at about $32,000. Los Angeles Capital Management LLC bought a new position in shares of Avantor in the fourth quarter worth about $32,000. Finally, Osaic Holdings Inc. boosted its stake in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after acquiring an additional 1,064 shares during the period. Institutional investors own 95.08% of the company’s stock.

Avantor News Summary

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Zacks raised its FY2026 EPS estimate to $0.80 from $0.78, FY2027 EPS to $0.85 from $0.84, and FY2028 EPS to $0.92 from $0.91. It also increased estimates for Q2 2027 to $0.22 from $0.19 and Q2 2028 to $0.23 from $0.22, pointing to somewhat improved longer-term earnings expectations.
• Positive Sentiment: The upward revisions support the recent strength in Avantor’s stock, particularly because the FY2027 estimate of $0.85 is above the current-year consensus estimate of $0.81. However, the improvements remain relatively small.
• Neutral Sentiment: Zacks’ “Hold” rating indicates that the firm sees a relatively balanced risk-reward profile. The analyst’s FY2026 EPS forecast of $0.80 is also slightly below the broader consensus estimate of $0.81.
• Neutral Sentiment: Recent coverage also compared Avantor’s year-to-date performance with BrightSpring Health Services and the broader medical sector, potentially drawing attention to AVTR’s relative performance. Is Avantor Outperforming Other Medical Stocks This Year?
• Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $0.22 from $0.23 and reduced Q1 2027 EPS to $0.18 from $0.19. It also trimmed Q3 2027 EPS to $0.22 from $0.23, partially offsetting the positive revisions.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.